Access cutting-edge breast cancer treatment through this clinical trial at a research site in Boston. Study-provided care at no cost to qualified participants.
Access breast cancer specialists in Boston at no cost
This study follows strict safety protocols and ethical guidelines
All study-related breast cancer treatment provided free
This phase II trial evaluates response-guided low-dose tamoxifen for reducing breast density in women who are at higher than average risk for breast cancer. Increasing breast density is a well established risk factor for breast cancer. Tamoxifen is a selective estrogen receptor modulator. It works by blocking the effects of the hormone estrogen in the breast. Tamoxifen has been shown to reduce breast density, even at reduced dosages, and is approved for the prevention of breast cancer.
Sponsor: National Cancer Institute (NCI)
Check if you qualify for this breast cancer clinical trial in Boston, MA
If you're searching for breast cancer treatment options in Boston, MA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Boston research site is actively enrolling participants for this clinical trial. You'll receive care from experienced breast cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.